Cargando…

Prediction of human pharmacokinetics for low‐clearance compounds using pharmacokinetic data from chimeric mice with humanized livers

Development of low‐clearance (CL) compounds that are slowly metabolized is a major goal in the pharmaceutical industry. However, the pursuit of low intrinsic CL (CL(int)) often leads to significant challenges in evaluating the pharmacokinetics of such compounds. Although in vitro–in vivo extrapolati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Kosuke, Doi, Yuki, Iwazaki, Norihiko, Yasuhara, Hidenori, Ikenaga, Yuka, Shimizu, Hidetoshi, Nakada, Tomohisa, Watanabe, Tomoko, Tateno, Chise, Sanoh, Seigo, Kotake, Yaichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742647/ https://www.ncbi.nlm.nih.gov/pubmed/34080287 http://dx.doi.org/10.1111/cts.13070

Ejemplares similares

Mild MPP(+) exposure-induced glucose starvation enhances autophagosome synthesis and impairs its degradation
por: Sakamoto, Shuichiro, et al.
Publicado: (2017)

Acetaminophen induces accumulation of functional rat CYP3A via polyubiquitination dysfunction
por: Santoh, Masataka, et al.
Publicado: (2016)

Characterization and applications of chimeric mice with humanized livers for preclinical drug development
por: Tateno, Chise, et al.
Publicado: (2020)

Development of a simple measurement method for GluR2 protein expression as an index of neuronal vulnerability
por: Sugiyama, Chihiro, et al.
Publicado: (2015)

Predicting human pharmacokinetics from preclinical data: clearance
por: Yim, Dong-Seok, et al.
Publicado: (2021)

Low-Concentration Tributyltin Decreases GluR2 Expression via Nuclear Respiratory Factor-1 Inhibition
por: Ishida, Keishi, et al.
Publicado: (2017)

Chimeric Mice with Humanized Livers: A Unique Tool for in Vivo and in Vitro Enzyme Induction Studies
por: Kakuni, Masakazu, et al.
Publicado: (2013)

Estimating Drug Efficacy with a Diet-Induced NASH Model in Chimeric Mice with Humanized Livers
por: Kisoh, Keishi, et al.
Publicado: (2021)

Drug Metabolism and Pharmacokinetics of Antisense Oligonucleotide Therapeutics: Typical Profiles, Evaluation Approaches, and Points to Consider Compared with Small Molecule Drugs
por: Takakusa, Hideo, et al.
Publicado: (2023)

A Human Hepatocyte-Bearing Mouse: An Animal Model to Predict Drug Metabolism and Effectiveness in Humans
por: Yoshizato, Katsutoshi, et al.
Publicado: (2009)

Detection of acute toxicity of aflatoxin B1 to human hepatocytes in vitro and in vivo using chimeric mice with humanized livers
por: Ishida, Yuji, et al.
Publicado: (2020)

Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance
por: Du, Bin, et al.
Publicado: (2021)

A Retrospective Evaluation of Allometry, Population Pharmacokinetics, and Physiologically‐Based Pharmacokinetics for Pediatric Dosing Using Clearance as a Surrogate
por: Wu, Qier, et al.
Publicado: (2019)

Prediction of Pharmacokinetics of IDP-73152 in Humans Using Physiologically-Based Pharmacokinetics
por: Lee, Myongjae, et al.
Publicado: (2022)

The pharmacokinetics of the interstitial space in humans
por: Levitt, David G
Publicado: (2003)

The pharmacokinetics of anthocyanins and their metabolites in humans
por: de Ferrars, R M, et al.
Publicado: (2014)

Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres
por: You, Jian, et al.
Publicado: (2014)

Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?
por: Germovsek, Eva, et al.
Publicado: (2016)

Measured GFR by Utilizing Population Pharmacokinetic Methods to Determine Iohexol Clearance
por: Åsberg, Anders, et al.
Publicado: (2019)

Physiologically Based Pharmacokinetic Modelling for Nicotine and Cotinine Clearance in Pregnant Women
por: Amice, Basile, et al.
Publicado: (2021)

NAD-dependent isocitrate dehydrogenase as a novel target of tributyltin in human embryonic carcinoma cells
por: Yamada, Shigeru, et al.
Publicado: (2014)

Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically‐Based Pharmacokinetic Modeling
por: Yellepeddi, Venkata K., et al.
Publicado: (2020)

Targeted Induction of Interferon-λ in Humanized Chimeric Mouse Liver Abrogates Hepatotropic Virus Infection
por: Nakagawa, Shin-ichiro, et al.
Publicado: (2013)

Culture density contributes to hepatic functions of fresh human hepatocytes isolated from chimeric mice with humanized livers: Novel, long-term, functional two-dimensional in vitro tool for developing new drugs
por: Yamasaki, Chihiro, et al.
Publicado: (2020)

Verifying in vitro‐determined enzyme contributions to cannabidiol clearance for exposure predictions in human through physiologically‐based pharmacokinetic modeling
por: Yeung, Cindy H. T., et al.
Publicado: (2023)

Designing receptor agonists with enhanced pharmacokinetics by grafting macrocyclic peptides into fragment crystallizable regions
por: Sakai, Katsuya, et al.
Publicado: (2022)

Pharmacokinetics of N,N-dimethyltryptamine in Humans
por: Good, Meghan, et al.
Publicado: (2023)

Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
por: Germovsek, Eva, et al.
Publicado: (2018)

Enhanced renal clearance and impact on vancomycin pharmacokinetic parameters in patients with hemorrhagic stroke
por: Morbitzer, Kathryn A., et al.
Publicado: (2019)

Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy
por: Andrews, Lauren, et al.
Publicado: (2021)

Lidocaine clearance as pharmacokinetic parameter of metabolic hepatic activity in patients with impaired liver
por: Jovanović, Marija, et al.
Publicado: (2023)

First-in-human study to investigate the safety and pharmacokinetics of salvianolic acid A and pharmacokinetic simulation using a physiologically based pharmacokinetic model
por: Chen, Jinliang, et al.
Publicado: (2022)

Application of a Pharmacokinetic Model of Metformin Clearance in a Population with Acute Myeloid Leukemia
por: Ceacareanu, Alice C., et al.
Publicado: (2018)

Correction to: Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
por: Germovsek, Eva, et al.
Publicado: (2018)

Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance
por: Zhao, Sixuan, et al.
Publicado: (2021)

Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model
por: Kloos, Robin Q.H., et al.
Publicado: (2020)

Evaluation of vancomycin pharmacokinetics in patients with augmented renal clearances: A randomized clinical trial
por: Sahraei, Zahra, et al.
Publicado: (2022)

P-glycoprotein efflux transporter: a key to pharmacokinetic modeling for methadone clearance in fetuses
por: Ho, Harvey, et al.
Publicado: (2023)

Individualized dosing guidelines for PEGasparaginase and factors influencing the clearance: a population pharmacokinetic model
por: Kloos, Robin Q.H., et al.
Publicado: (2023)

Human physiologically based pharmacokinetic model for propofol
por: Levitt, David G, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_pabrt90pdte6u3q3onltfud2di